Hemotune AG raised €7.1M in a Series B round in Apr 2022. The company is based in Zurich, Switzerland. Investors in the round: Hemex, OCCIDENT, VP Venture Partners and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
